Dr. Ayca Gucalp, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Breast Cancer
Studies Relapse
5 reported clinical trials
10 drugs studied
Area of expertise
1Breast Cancer
Stage IV
AR positive
HER2 negative
2Relapse
Stage III
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Ayca Gucalp, MD is currently running
MELK Inhibitor OTS167PO
for Breast Cancer
This trial is testing a pill called OTS167 to find out the highest dose that patients with advanced breast cancer can safely take.
Recruiting1 award Phase 114 criteria
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting1 award Phase 218 criteria
More about Ayca Gucalp, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ayca Gucalp, MD has experience with
- Bicalutamide
- Palbociclib
- Olaparib
- Pembrolizumab
- Ipilimumab
- Nivolumab
Breakdown of trials Ayca Gucalp, MD has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ayca Gucalp, MD specialize in?
Ayca Gucalp, MD focuses on Breast Cancer and Relapse. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are AR positive.
Is Ayca Gucalp, MD currently recruiting for clinical trials?
Yes, Ayca Gucalp, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ayca Gucalp, MD has studied deeply?
Yes, Ayca Gucalp, MD has studied treatments such as Bicalutamide, Palbociclib, Olaparib.
What is the best way to schedule an appointment with Ayca Gucalp, MD?
Apply for one of the trials that Ayca Gucalp, MD is conducting.
What is the office address of Ayca Gucalp, MD?
The office of Ayca Gucalp, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.